About
Pallando Therapeutics develops tissue-sparing protein degraders, focusing on targeted protein degradation therapies.
Explore Pallando Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.